Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Anthera Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

    Headlines

    Mon, 20 May 2013

    Anthera Pharmaceuticals ( ANTH ) Q1 2013 Earnings Call May 20, 2013 5:00 pm ET Executives ..... http://seekingalpha.com/article/1448541-anthera- pharmaceuticals -management-discusses-q1-2013-results-earnings-call

  2. U.S. court ruling favors Cubist in patent case versus Hospira

    Headlines

    Mon, 20 May 2013

    (Reuters) - A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc .

  3. U.S. court ruling favors Cubist in patent case vs Hospira

    Headlines

    Mon, 20 May 2013

    May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc.

  4. Spectrum Pharmaceuticals , Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM

    Headlines

    Mon, 20 May 2013

    Spectrum Pharmaceuticals , Inc. ( SPPI ) May 20, 2013 ..... President and CEO of Spectrum Pharmaceuticals . We will have a breakout session ..... the West Coast called Spectrum Pharmaceuticals . We are focused on oncology

  5. Regeneron settles all pending litigation with Roche's Genentech

    Headlines

    Mon, 20 May 2013

    May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap.

  6. Astex Pharmaceuticals , Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM

    Headlines

    Mon, 20 May 2013

    Astex Pharmaceuticals , Inc. ( ASTX ) May 20, 2013 ..... Manuso, Chairman and CEO of Astex Pharmaceuticals . There will be a breakout session ..... com/article/1448421-astex- pharmaceuticals -inc-presents-at-ubs-global

  7. Ironwood Pharmaceuticals (IRWD) announces a 10.5M share public offering, with a 30-day option to purchase up to an additional 1,575,000 shares. All of the shares are being offered by the company, ...

    Headlines

    Mon, 20 May 2013

    Ironwood Pharmaceuticals ( IRWD ) announces a 10.5M share public offering , with a 30-day option to purchase up to an additional 1,575,000 shares

  8. Cubist Pharmaceuticals ([[CBST]] +11.3%) spikes to session highs. The move appears relates to an apparent Markman ruling on Hospira (HSP +0.7%, which has a generic version of Cubist's drug Cubicin. ...

    Headlines

    Mon, 20 May 2013

    Cubist Pharmaceuticals ( CBST +11.3% ) spikes to session highs. The move appears relates to an apparent Markman ruling on Hospira (HSP +0.7

  9. Johnson & Johnson's Short-Term Pipeline

    Headlines

    Mon, 20 May 2013

    By Jean-Christophe Larsimont: What remains in the pipeline of the eighth largest pharmaceuticals company after the recent approval of its last jackpot ? Introduction You will find a comprehensive dividend stock analysis of Johnson

  10. Regeneron Pharmaceuticals , Inc. Presents at UBS Global Healthcare Conference, May-20-2013 10:00 AM

    Headlines

    Mon, 20 May 2013

    Regeneron Pharmaceuticals , Inc. ( REGN ) May 20, 2013 10:00 am ET Executives Murray ..... http://seekingalpha.com/article/1447681-regeneron- pharmaceuticals -inc-presents-at-ubs-global-healthcare-conference

« Prev12345Next »
Content Partners